Expansion of the GSK Vaccine Manufacturing Plant in Gödöllő

The expansion of GlaxoSmithKline's (GSK) vaccine manufacturing plant in Gödöllő aimed to increase production capacity for components used in diphtheria and tetanus vaccines. The development included the construction of a new production building (GD15) and the extension of an existing facility (GD07). The new and modified areas incorporated conventional and cleanroom facilities, along with dedicated changing rooms separating different hygiene zones.

Our responsibilities included the preparation of architectural and structural concept designs, building permit and detailed construction documentation, as well as design supervision during construction.

One of the key engineering considerations was the integration of the new facilities with the existing buildings. The specific requirements of pharmaceutical manufacturing, particularly the separation of conventional and cleanroom areas, required careful attention to architectural and structural design.

The approximately HUF 18 billion investment created 104 new jobs in Gödöllő and contributed to expanding GSK's international vaccine manufacturing capacity. The development also strengthened Hungary's role in the global pharmaceutical supply chain.